Short answer · Medically reviewed summary · Last updated: 2026-04-07
Crouzon syndrome is classified under the ICD-10-CM code Q75.0 (Craniosynostosis) and the ICD-9-CM code 756.0 (Anomalies of skull and face bones). These billing codes are essential for healthcare providers to document the condition, though they represent the broader category of craniosynostosis syndromes rather than a unique code exclusive to Crouzon syndrome. What is the clinical classification of Crouzon syndrome? Crouzon syndrome is a rare genetic disorder characterized by the premature fusion of certain skull bones (craniosynostosis), which prevents the skull from growing normally and affects the shape of the head and face.
Crouzon syndrome is classified under the ICD-10-CM code Q75.0 (Craniosynostosis) and the ICD-9-CM code 756.0 (Anomalies of skull and face bones). These billing codes are essential for healthcare providers to document the condition, though they represent the broader category of craniosynostosis syndromes rather than a unique code exclusive to Crouzon syndrome.
Crouzon syndrome is a rare genetic disorder characterized by the premature fusion of certain skull bones (craniosynostosis), which prevents the skull from growing normally and affects the shape of the head and face. Because the condition is a form of craniosynostosis, medical coding often utilizes the ICD-10 code Q75.0. Clinically, Crouzon syndrome is identified by its distinct craniofacial features, including widely spaced eyes (hypertelorism), shallow eye sockets (proptosis), and an underdeveloped upper jaw. Within the DiseaseMaps.org community, 91 individuals have shared their experiences, highlighting the diverse ways this diagnosis impacts daily life and long-term health management.
Diagnosis of Crouzon syndrome is typically made through a combination of clinical evaluation and genetic testing. Physicians often look for the hallmark signs of craniosynostosis shortly after birth. When billing for services related to Crouzon syndrome, medical professionals use ICD-10-CM Q75.0, which encompasses various syndromes involving the premature closure of cranial sutures. In older medical records, the ICD-9-CM code 756.0 was used to describe these specific anomalies of the skull and face bones. It is common for patients to have multiple secondary codes in their records to account for related complications, such as obstructive sleep apnea or visual impairments.
Crouzon syndrome is an autosomal dominant condition, meaning that an affected parent has a 50% chance of passing the mutated FGFR2 gene to each child. However, it is important to note that many cases occur as a "de novo" or spontaneous mutation in an individual with no previous family history of the condition. Genetic counseling is highly recommended for families navigating a new diagnosis of Crouzon syndrome to understand the recurrence risks and the molecular basis of the disorder.
Management of Crouzon syndrome requires a multidisciplinary approach involving pediatric neurosurgeons, craniofacial surgeons, ophthalmologists, and geneticists. The following list details common clinical areas that may require ongoing monitoring:
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.